{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:37:06Z","timestamp":1790113026054,"version":"4.0.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LQN25H160037"],"award-info":[{"award-number":["LQN25H160037"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32171368"],"award-info":[{"award-number":["32171368"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Pioneer and Leading Goose R&D Program of Zhejiang","award":["2025C04007"],"award-info":[{"award-number":["2025C04007"]}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2023ZD59"],"award-info":[{"award-number":["ZR2023ZD59"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Project of Jinan Microecological Biomedicine Shandong Laboratory","award":["No.JNL-2025007B"],"award-info":[{"award-number":["No.JNL-2025007B"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04196-6","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T12:46:48Z","timestamp":1771850808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Macrophage-delivered Nifuroxazide reprograms immunosuppressive microenvironment and synergizes with oxaliplatin for enhanced anti-hepatocellular carcinoma therapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhentao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengliang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"4196_CR1","doi-asserted-by":"crossref","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiol Hepatocellular Carcinoma Hepatol. 2021;73 Suppl 1:4\u201313.","DOI":"10.1002\/hep.31288"},{"issue":"1","key":"4196_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"4196_CR3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.tips.2013.06.005","volume":"34","author":"SC Gupta","year":"2013","unstructured":"Gupta SC, Sung B, Prasad S, Webb LJ, Aggarwal BB. Cancer drug discovery by repurposing: teaching new tricks to old dogs. Trends Pharmacol Sci. 2013;34(9):508\u201317.","journal-title":"Trends Pharmacol Sci"},{"key":"4196_CR4","doi-asserted-by":"publisher","first-page":"e1701","DOI":"10.1038\/cddis.2015.63","volume":"6","author":"F Yang","year":"2015","unstructured":"Yang F, Hu M, Lei Q, Xia Y, Zhu Y, Song X, et al. Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model. Cell Death Dis. 2015;6:e1701.","journal-title":"Cell Death Dis"},{"issue":"13","key":"4196_CR5","doi-asserted-by":"publisher","first-page":"5095","DOI":"10.1182\/blood-2007-12-129718","volume":"112","author":"EA Nelson","year":"2008","unstructured":"Nelson EA, Walker SR, Kepich A, Gashin LB, Hideshima T, Ikeda H, et al. Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3. Blood. 2008;112(13):5095\u2013102.","journal-title":"Blood"},{"issue":"1","key":"4196_CR6","doi-asserted-by":"publisher","first-page":"e2534","DOI":"10.1038\/cddis.2016.452","volume":"8","author":"T-H Ye","year":"2017","unstructured":"Ye T-H, Yang F-F, Zhu Y-X, Li Y-L, Lei Q, Song X-J, et al. Inhibition of Stat3 signaling pathway by Nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis. Cell Death Dis. 2017;8(1):e2534.","journal-title":"Cell Death Dis"},{"issue":"9","key":"4196_CR7","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1016\/j.drudis.2019.06.017","volume":"24","author":"C Bailly","year":"2019","unstructured":"Bailly C. Toward a repositioning of the antibacterial drug Nifuroxazide for cancer treatment. Drug Discov Today. 2019;24(9):1930\u20136.","journal-title":"Drug Discov Today"},{"issue":"6","key":"4196_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","volume":"14","author":"JL Alexander","year":"2017","unstructured":"Alexander JL, Wilson ID, Teare J, Marchesi JR, Nicholson JK, Kinross JM. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol. 2017;14(6):356\u201365.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"4196_CR9","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41591-023-02234-6","volume":"29","author":"CK Stein-Thoeringer","year":"2023","unstructured":"Stein-Thoeringer CK, Saini NY, Zamir E, Blumenberg V, Schubert ML, Mor U, et al. A non-antibiotic-disrupted gut Microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy. Nat Med. 2023;29(4):906\u201316.","journal-title":"Nat Med"},{"issue":"6","key":"4196_CR10","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.chom.2025.05.004","volume":"33","author":"X Ding","year":"2025","unstructured":"Ding X, Ting NL, Wong CC, Huang P, Jiang L, Liu C, et al. Bacteroides fragilis promotes chemoresistance in colorectal cancer, and its elimination by phage VA7 restores chemosensitivity. Cell Host Microbe. 2025;33(6):941\u2013e95610.","journal-title":"Cell Host Microbe"},{"key":"4196_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jconrel.2015.12.048","volume":"223","author":"EC Wayne","year":"2016","unstructured":"Wayne EC, Chandrasekaran S, Mitchell MJ, Chan MF, Lee RE, Schaffer CB, et al. TRAIL-coated leukocytes that prevent the bloodborne metastasis of prostate cancer. J Control Release. 2016;223:215\u201323.","journal-title":"J Control Release"},{"key":"4196_CR12","doi-asserted-by":"publisher","first-page":"114300","DOI":"10.1016\/j.addr.2022.114300","volume":"185","author":"T Zhang","year":"2022","unstructured":"Zhang T, Lin R, Wu H, Jiang X, Gao J. Mesenchymal stem cells: A living carrier for active tumor-targeted delivery. Adv Drug Deliv Rev. 2022;185:114300.","journal-title":"Adv Drug Deliv Rev"},{"key":"4196_CR13","doi-asserted-by":"crossref","unstructured":"Hu A, Chen H, Liang J, Liu C, Li F, Mu C. Cell-based therapeutics for the treatment of hematologic diseases inside the bone marrow. J Control Release. 2021;339:1\u2013\u201313.","DOI":"10.1016\/j.jconrel.2021.09.018"},{"issue":"40","key":"4196_CR14","doi-asserted-by":"publisher","first-page":"e2002054","DOI":"10.1002\/adma.202002054","volume":"32","author":"Y Xia","year":"2020","unstructured":"Xia Y, Rao L, Yao H, Wang Z, Ning P, Chen X. Engineering macrophages for cancer immunotherapy and drug delivery. Adv Mater. 2020;32(40):e2002054.","journal-title":"Adv Mater"},{"key":"4196_CR15","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.2147\/IJN.S110146","volume":"11","author":"S Li","year":"2016","unstructured":"Li S, Feng S, Ding L, Liu Y, Zhu Q, Qian Z, et al. Nanomedicine engulfed by macrophages for targeted tumor therapy. Int J Nanomed. 2016;11:4107\u201324.","journal-title":"Int J Nanomed"},{"issue":"2","key":"4196_CR16","first-page":"1078","volume":"13","author":"L Guo","year":"2019","unstructured":"Guo L, Zhang Y, Yang Z, Peng H, Wei R, Wang C, et al. Tunneling nanotubular expressways for ultrafast and accurate M1 macrophage delivery of anticancer drugs to metastatic ovarian carcinoma. ACS Nano. 2019;13(2):1078\u201396.","journal-title":"ACS Nano"},{"issue":"21","key":"4196_CR17","doi-asserted-by":"publisher","first-page":"1900582","DOI":"10.1002\/advs.201900582","volume":"6","author":"EC Wayne","year":"2019","unstructured":"Wayne EC, Long C, Haney MJ, Batrakova EV, Leisner TM, Parise LV, et al. Targeted delivery of SiRNA lipoplexes to cancer cells using macrophage transient horizontal gene transfer. Adv Sci (Weinh). 2019;6(21):1900582.","journal-title":"Adv Sci (Weinh)"},{"issue":"13","key":"4196_CR18","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.7150\/thno.99257","volume":"14","author":"W Liu","year":"2024","unstructured":"Liu W, Cheng G, Cui H, Tian Z, Li B, Han Y, et al. Theoretical basis, state and challenges of living cell-based drug delivery systems. Theranostics. 2024;14(13):5152\u201383.","journal-title":"Theranostics"},{"issue":"15","key":"4196_CR19","doi-asserted-by":"publisher","first-page":"e1807211","DOI":"10.1002\/adma.201807211","volume":"31","author":"C-X Li","year":"2019","unstructured":"Li C-X, Zhang Y, Dong X, Zhang L, Liu M-D, Li B, et al. Artificially reprogrammed macrophages as Tumor-Tropic Immunosuppression-Resistant biologics to realize therapeutics production and immune activation. Adv Mater. 2019;31(15):e1807211.","journal-title":"Adv Mater"},{"issue":"1","key":"4196_CR20","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1186\/s12967-023-04716-0","volume":"21","author":"J Huang","year":"2023","unstructured":"Huang J, Wu Q, Geller DA, Yan Y. Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC). J Transl Med. 2023;21(1):815.","journal-title":"J Transl Med"},{"issue":"11","key":"4196_CR21","doi-asserted-by":"publisher","first-page":"9419","DOI":"10.1002\/jcb.27259","volume":"119","author":"Z Yin","year":"2018","unstructured":"Yin Z, Ma T, Lin Y, Lu X, Zhang C, Chen S, et al. IL-6\/STAT3 pathway intermediates M1\/M2 macrophage polarization during the development of hepatocellular carcinoma. J Cell Biochem. 2018;119(11):9419\u201332.","journal-title":"J Cell Biochem"},{"issue":"2","key":"4196_CR22","doi-asserted-by":"publisher","first-page":"963","DOI":"10.7150\/thno.65411","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Wang J, Zhao J, Wang H, Chen J, Wu J. HMGA2 facilitates colorectal cancer progression via STAT3-mediated tumor-associated macrophage recruitment. Theranostics. 2022;12(2):963\u201375.","journal-title":"Theranostics"},{"issue":"8","key":"4196_CR23","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.7150\/ijbs.70289","volume":"18","author":"W Zhang","year":"2022","unstructured":"Zhang W, Zheng X, Yu Y, Zheng L, Lan J, Wu Y, et al. Renal cell carcinoma-derived exosomes deliver LncARSR to induce macrophage polarization and promote tumor progression via STAT3 pathway. Int J Biol Sci. 2022;18(8):3209\u201322.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"4196_CR24","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1002\/jcb.29432","volume":"121","author":"T Zhao","year":"2020","unstructured":"Zhao T, Feng Y, Guo M, Zhang C, Wu Q, Chen J, et al. Combination of attenuated Salmonella carrying PD-1 SiRNA with Nifuroxazide for colon cancer therapy. J Cell Biochem. 2020;121(2):1973\u201385.","journal-title":"J Cell Biochem"},{"issue":"1","key":"4196_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0092-8674(78)90101-0","volume":"15","author":"WC Raschke","year":"1978","unstructured":"Raschke WC, Baird S, Ralph P, Nakoinz I. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell. 1978;15(1):261\u20137.","journal-title":"Cell"},{"issue":"1","key":"4196_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jhep.2018.02.008","volume":"69","author":"N Lyu","year":"2018","unstructured":"Lyu N, Kong Y, Mu L, Lin Y, Li J, Liu Y, et al. Hepatic arterial infusion of oxaliplatin plus fluorouracil\/leucovorin vs. sorafenib for advanced hepatocellular carcinoma. J Hepatol. 2018;69(1):60\u20139.","journal-title":"J Hepatol"},{"issue":"5","key":"4196_CR27","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1200\/JCO.21.01963","volume":"40","author":"N Lyu","year":"2022","unstructured":"Lyu N, Wang X, Li J-B, Lai J-F, Chen Q-F, Li S-L, et al. Arterial chemotherapy of oxaliplatin plus fluorouracil versus Sorafenib in advanced hepatocellular carcinoma: A biomolecular Exploratory, Randomized, phase III trial (FOHAIC-1). J Clin Oncol. 2022;40(5):468\u201380.","journal-title":"J Clin Oncol"},{"issue":"2","key":"4196_CR28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1200\/JCO.21.00608","volume":"40","author":"Q-J Li","year":"2022","unstructured":"Li Q-J, He M-K, Chen H-W, Fang W-Q, Zhou Y-M, Xu L, et al. Hepatic arterial infusion of Oxaliplatin, Fluorouracil, and leucovorin versus transarterial chemoembolization for large hepatocellular carcinoma: A randomized phase III trial. J Clin Oncol. 2022;40(2):150\u201360.","journal-title":"J Clin Oncol"},{"key":"4196_CR29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.canlet.2019.10.020","volume":"469","author":"Z Liu","year":"2020","unstructured":"Liu Z, Xie Y, Xiong Y, Liu S, Qiu C, Zhu Z, et al. TLR 7\/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages. Cancer Lett. 2020;469:173\u201385.","journal-title":"Cancer Lett"},{"issue":"7","key":"4196_CR30","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1016\/j.apsb.2024.02.024","volume":"14","author":"J Li","year":"2024","unstructured":"Li J, Zhang Q, Yang H, Lu W, Fu Y, Xiong Y, et al. Sequential dual-locking strategy using photoactivated Pt(IV)-based metallo-nano prodrug for enhanced chemotherapy and photodynamic efficacy by triggering ferroptosis and macrophage polarization. Acta Pharm Sin B. 2024;14(7):3251\u201365.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"4196_CR31","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1038\/emm.2013.135","volume":"46","author":"DI Cho","year":"2014","unstructured":"Cho DI, Kim MR, Jeong HY, Jeong HC, Jeong MH, Yoon SH, et al. Mesenchymal stem cells reciprocally regulate the M1\/M2 balance in mouse bone marrow-derived macrophages. Exp Mol Med. 2014;46(1):e70.","journal-title":"Exp Mol Med"},{"key":"4196_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jconrel.2015.01.039","volume":"204","author":"J Fu","year":"2015","unstructured":"Fu J, Wang D, Mei D, Zhang H, Wang Z, He B, et al. Macrophage mediated biomimetic delivery system for the treatment of lung metastasis of breast cancer. J Control Release. 2015;204:11\u20139.","journal-title":"J Control Release"},{"issue":"4","key":"4196_CR33","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","volume":"79","author":"AD Ladd","year":"2024","unstructured":"Ladd AD, Duarte S, Sahin I, Zarrinpar A. Mechanisms of drug resistance in HCC. Hepatology. 2024;79(4):926\u201340.","journal-title":"Hepatology"},{"issue":"6","key":"4196_CR34","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41556-020-0507-y","volume":"22","author":"JM Perry","year":"2020","unstructured":"Perry JM, Tao F, Roy A, Lin T, He XC, Chen S, et al. Overcoming Wnt-\u03b2-catenin dependent anticancer therapy resistance in leukaemia stem cells. Nat Cell Biol. 2020;22(6):689\u2013700.","journal-title":"Nat Cell Biol"},{"issue":"6","key":"4196_CR35","doi-asserted-by":"publisher","first-page":"e0279221","DOI":"10.1128\/mBio.02792-21","volume":"12","author":"L Koujah","year":"2021","unstructured":"Koujah L, Madavaraju K, Agelidis AM, Patil CD, Shukla D. Heparanase-Induced activation of AKT stabilizes \u03b2-Catenin and modulates Wnt\/\u03b2-Catenin signaling during herpes simplex virus 1 infection. mBio. 2021;12(6):e0279221.","journal-title":"mBio"},{"issue":"41","key":"4196_CR36","doi-asserted-by":"publisher","first-page":"6451","DOI":"10.1038\/s41388-020-01446-1","volume":"39","author":"Y Su","year":"2020","unstructured":"Su Y, Wang X, Guo Z, Wang J. Aberrant JmjC domain-containing protein 8 (JMJD8) expression promotes activation of AKT and tumor epithelial-mesenchymal transition. Oncogene. 2020;39(41):6451\u201367.","journal-title":"Oncogene"},{"issue":"1","key":"4196_CR37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jhep.2019.08.035","volume":"72","author":"TB Toh","year":"2020","unstructured":"Toh TB, Lim JJ, Hooi L, Rashid M, Chow EK. Targeting Jak\/Stat pathway as a therapeutic strategy against SP\/CD44\u2009+\u2009tumorigenic cells in Akt\/\u03b2-catenin-driven hepatocellular carcinoma. J Hepatol. 2020;72(1):104\u201318.","journal-title":"J Hepatol"},{"key":"4196_CR38","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.freeradbiomed.2021.10.010","volume":"176","author":"JB Seong","year":"2021","unstructured":"Seong JB, Kim B, Kim S, Kim MH, Park Y-H, Lee Y, et al. Macrophage Peroxiredoxin 5 deficiency promotes lung cancer progression via ROS-dependent M2-like polarization. Free Radic Biol Med. 2021;176:322\u201334.","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"4196_CR39","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/cr.2013.75","volume":"23","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Choksi S, Chen K, Pobezinskaya Y, Linnoila I, Liu Z-G. ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages. Cell Res. 2013;23(7):898\u2013914.","journal-title":"Cell Res"},{"issue":"1","key":"4196_CR40","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1038\/s41467-021-23164-2","volume":"12","author":"Y-C Wang","year":"2021","unstructured":"Wang Y-C, Wang X, Yu J, Ma F, Li Z, Zhou Y, et al. Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy. Nat Commun. 2021;12(1):3530.","journal-title":"Nat Commun"},{"key":"4196_CR41","doi-asserted-by":"crossref","unstructured":"Wang K, Zhang K, Zhang X, Chen D, Jiang S. Recent insights of Metformin on hepatocellular carcinoma (HCC). Mini Rev Med Chem. 2023;23(11):1154\u2013\u20131166.","DOI":"10.2174\/1389557522666220623150717"},{"issue":"14","key":"4196_CR42","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1158\/0008-5472.CAN-21-0758","volume":"81","author":"E Ricciotti","year":"2021","unstructured":"Ricciotti E, Wangensteen KJ, FitzGerald GA. Aspirin in hepatocellular carcinoma. Cancer Res. 2021;81(14):3751\u201361.","journal-title":"Cancer Res"},{"issue":"1","key":"4196_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13046-020-1528-x","volume":"39","author":"J Feng","year":"2020","unstructured":"Feng J, Dai W, Mao Y, Wu L, Li J, Chen K, et al. Simvastatin re-sensitizes hepatocellular carcinoma cells to Sorafenib by inhibiting HIF-1\u03b1\/PPAR-\u03b3\/PKM2-mediated Glycolysis. J Exp Clin Cancer Res. 2020;39(1):24.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"4196_CR44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","volume":"42","author":"Z-J Li","year":"2021","unstructured":"Li Z-J, Dai H-Q, Huang X-W, Feng J, Deng J-H, Wang Z-X, et al. Artesunate synergizes with Sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacol Sin. 2021;42(2):301\u201310.","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"4196_CR45","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/hep.27968","volume":"62","author":"C Won","year":"2015","unstructured":"Won C, Kim B-H, Yi EH, Choi K-J, Kim E-K, Jeong J-M, et al. Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma. Hepatology. 2015;62(4):1160\u201373.","journal-title":"Hepatology"},{"issue":"9","key":"4196_CR46","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1101\/gr.154492.113","volume":"23","author":"Z Kan","year":"2013","unstructured":"Kan Z, Zheng H, Liu X, Li S, Barber TD, Gong Z, et al. Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res. 2013;23(9):1422\u201333.","journal-title":"Genome Res"},{"issue":"1","key":"4196_CR47","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/hep.21467","volume":"45","author":"S Boyault","year":"2007","unstructured":"Boyault S, Rickman DS, de Reyni\u00e8s A, Balabaud C, Rebouissou S, Jeannot E, et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology. 2007;45(1):42\u201352.","journal-title":"Hepatology"},{"issue":"20","key":"4196_CR48","doi-asserted-by":"publisher","first-page":"18074","DOI":"10.1021\/acsami.9b01343","volume":"11","author":"SK Misra","year":"2019","unstructured":"Misra SK, Wu Z, Ostadhossein F, Ye M, Boateng K, Schulten K, et al. Pro-Nifuroxazide Self-Assembly leads to triggerable nanomedicine for Anti-cancer therapy. ACS Appl Mater Interfaces. 2019;11(20):18074\u201389.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4196_CR49","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jconrel.2020.07.043","volume":"327","author":"F Combes","year":"2020","unstructured":"Combes F, Meyer E, Sanders NN. Immune cells as tumor drug delivery vehicles. J Control Release. 2020;327:70\u201387.","journal-title":"J Control Release"},{"key":"4196_CR50","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jconrel.2018.09.007","volume":"288","author":"Y Umeki","year":"2018","unstructured":"Umeki Y, Saito M, Kusamori K, Tsujimura M, Nishimura M, Takahashi Y, et al. Combined encapsulation of a tumor antigen and immune cells using a self-assembling immunostimulatory DNA hydrogel to enhance antigen-specific tumor immunity. J Control Release. 2018;288:189\u201398.","journal-title":"J Control Release"},{"issue":"1","key":"4196_CR51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12951-019-0513-z","volume":"17","author":"L Qiang","year":"2019","unstructured":"Qiang L, Cai Z, Jiang W, Liu J, Tai Z, Li G, et al. A novel macrophage-mediated biomimetic delivery system with NIR-triggered release for prostate cancer therapy. J Nanobiotechnol. 2019;17(1):83.","journal-title":"J Nanobiotechnol"},{"issue":"22","key":"4196_CR52","doi-asserted-by":"publisher","first-page":"14441","DOI":"10.1021\/acsnano.4c01120","volume":"18","author":"C Hu","year":"2024","unstructured":"Hu C, Wang J, Gao X, Xia J, Li W, Song P, et al. Pluronic-Based nanoparticles for delivery of doxorubicin to the tumor microenvironment by binding to macrophages. ACS Nano. 2024;18(22):14441\u201356.","journal-title":"ACS Nano"},{"key":"4196_CR53","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.actbio.2024.07.042","volume":"186","author":"X Zhang","year":"2024","unstructured":"Zhang X, Yue L, Cao L, Liu K, Yang S, Liang S, et al. Tumor microenvironment-responsive macrophage-mediated immunotherapeutic drug delivery. Acta Biomater. 2024;186:369\u201382.","journal-title":"Acta Biomater"},{"key":"4196_CR54","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.jconrel.2023.11.046","volume":"365","author":"M Zhou","year":"2024","unstructured":"Zhou M, Wu Y, Sun M, Qin Y, Zhao J, Qiu Z, et al. Spatiotemporally sequential delivery of biomimetic liposomes potentiates glioma chemotherapy. J Control Release. 2024;365:876\u201388.","journal-title":"J Control Release"},{"issue":"1","key":"4196_CR55","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/jcb.22110","volume":"107","author":"B Zhang","year":"2009","unstructured":"Zhang B, Wang J, Gao J, Guo Y, Chen X, Wang B, et al. Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma. J Cell Biochem. 2009;107(1):134\u201343.","journal-title":"J Cell Biochem"},{"issue":"6371","key":"4196_CR56","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daill\u00e8re R, et al. Gut Microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359(6371):91\u20137.","journal-title":"Science"},{"issue":"10","key":"4196_CR57","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s41423-022-00902-0","volume":"19","author":"G Morris","year":"2022","unstructured":"Morris G, Gevezova M, Sarafian V, Maes M. Redox regulation of the immune response. Cell Mol Immunol. 2022;19(10):1079\u2013101.","journal-title":"Cell Mol Immunol"},{"key":"4196_CR58","doi-asserted-by":"publisher","first-page":"101116","DOI":"10.1016\/j.redox.2019.101116","volume":"22","author":"J Zhang","year":"2019","unstructured":"Zhang J, Li H, Wu Q, Chen Y, Deng Y, Yang Z, et al. Tumoral NOX4 recruits M2 tumor-associated macrophages via ROS\/PI3K signaling-dependent various cytokine production to promote NSCLC growth. Redox Biol. 2019;22:101116.","journal-title":"Redox Biol"},{"issue":"1","key":"4196_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s11658-023-00438-9","volume":"28","author":"M Hashemi","year":"2023","unstructured":"Hashemi M, Sabouni E, Rahmanian P, Entezari M, Mojtabavi M, Raei B, et al. Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and Pharmacological significance. Cell Mol Biol Lett. 2023;28(1):33.","journal-title":"Cell Mol Biol Lett"},{"issue":"15","key":"4196_CR60","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.2174\/1381612826666200131100630","volume":"26","author":"SH Shahcheraghi","year":"2020","unstructured":"Shahcheraghi SH, Tchokonte-Nana V, Lotfi M, Lotfi M, Ghorbani A, Sadeghnia HR. Wnt\/beta-catenin and PI3K\/Akt\/mTOR signaling pathways in glioblastoma: two main targets for drug design: A review. Curr Pharm Des. 2020;26(15):1729\u201341.","journal-title":"Curr Pharm Des"},{"key":"4196_CR61","doi-asserted-by":"publisher","first-page":"104806","DOI":"10.1016\/j.phrs.2020.104806","volume":"156","author":"P Jabbarzadeh Kaboli","year":"2020","unstructured":"Jabbarzadeh Kaboli P, Salimian F, Aghapour S, Xiang S, Zhao Q, Li M, et al. Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer - A comprehensive review from chemotherapy to immunotherapy. Pharmacol Res. 2020;156:104806.","journal-title":"Pharmacol Res"},{"issue":"1","key":"4196_CR62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13046-021-02229-6","volume":"41","author":"S Dong","year":"2022","unstructured":"Dong S, Liang S, Cheng Z, Zhang X, Luo L, Li L, et al. ROS\/PI3K\/Akt and Wnt\/\u03b2-catenin signalings activate HIF-1\u03b1-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer. J Exp Clin Cancer Res. 2022;41(1):15.","journal-title":"J Exp Clin Cancer Res"},{"issue":"23","key":"4196_CR63","doi-asserted-by":"publisher","first-page":"7375","DOI":"10.1158\/1078-0432.CCR-17-1283","volume":"23","author":"Y Yin","year":"2017","unstructured":"Yin Y, Yao S, Hu Y, Feng Y, Li M, Bian Z, et al. The Immune-microenvironment confers chemoresistance of colorectal cancer through Macrophage-Derived IL6. Clin Cancer Res. 2017;23(23):7375\u201387.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"4196_CR64","doi-asserted-by":"publisher","first-page":"101202","DOI":"10.1016\/j.tranon.2021.101202","volume":"14","author":"F Li","year":"2021","unstructured":"Li F, Zheng X, Wang X, Xu J, Zhang Q. Macrophage polarization synergizes with oxaliplatin in lung cancer immunotherapy via enhanced tumor cell phagocytosis. Transl Oncol. 2021;14(11):101202.","journal-title":"Transl Oncol"},{"issue":"4","key":"4196_CR65","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41388-018-0449-z","volume":"38","author":"P Guha","year":"2019","unstructured":"Guha P, Gardell J, Darpolor J, Cunetta M, Lima M, Miller G, et al. STAT3 Inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells. Oncogene. 2019;38(4):533\u201348.","journal-title":"Oncogene"},{"key":"4196_CR66","doi-asserted-by":"crossref","unstructured":"Bitsch R, Kurzay A, \u00d6zbay Kurt F, De La Torre C, Lasser S, Lepper A et al. STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice. J Immunother Cancer. 2022;10(3):e004384.","DOI":"10.1136\/jitc-2021-004384"},{"issue":"4","key":"4196_CR67","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/15384101.2018.1444305","volume":"17","author":"X Mu","year":"2018","unstructured":"Mu X, Shi W, Xu Y, Xu C, Zhao T, Geng B, et al. Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK\/STAT3 signaling pathway in breast cancer. Cell Cycle. 2018;17(4):428\u201338.","journal-title":"Cell Cycle"},{"issue":"4","key":"4196_CR68","doi-asserted-by":"publisher","first-page":"101377","DOI":"10.1016\/j.jcmgh.2024.101377","volume":"18","author":"W Liu","year":"2024","unstructured":"Liu W, Zhang F, Quan B, Yao F, Chen R, Ren Z, et al. DDR2\/STAT3 positive feedback loop mediates the immunosuppressive microenvironment by upregulating PD-L1 and recruiting MDSCs in Oxaliplatin-Resistant HCC. Cell Mol Gastroenterol Hepatol. 2024;18(4):101377.","journal-title":"Cell Mol Gastroenterol Hepatol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04196-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04196-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04196-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T16:03:14Z","timestamp":1774886594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04196-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4196"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04196-6","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments involving animals were conducted in compliance with the National Institute Guide for the Care and Use of Laboratory Animals. The Ethics Committee of the First Affiliated Hospital, School of Medicine, Zhejiang University approved the experimental protocol used in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"297"}}